121 related articles for article (PubMed ID: 32860839)
1. Doxorubicin exhibits strong and selective association with VEGF Pu
Bilgen E; Persil Çetinkol Ö
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129720. PubMed ID: 32860839
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Parallel G-Quadruplex Nucleic Acid World: A Spectroscopic and Computational Investigation on the Binding of the c-myc Oncogene NHE III1 Region by the Phytochemical Polydatin.
Greco F; Musumeci D; Borbone N; Falanga AP; D'Errico S; Terracciano M; Piccialli I; Roviello GN; Oliviero G
Molecules; 2022 May; 27(9):. PubMed ID: 35566347
[TBL] [Abstract][Full Text] [Related]
3. Nemorubicin and doxorubicin bind the G-quadruplex sequences of the human telomeres and of the c-MYC promoter element Pu22.
Scaglioni L; Mondelli R; Artali R; Sirtori FR; Mazzini S
Biochim Biophys Acta; 2016 Jun; 1860(6):1129-38. PubMed ID: 26922833
[TBL] [Abstract][Full Text] [Related]
4. Electrochemical detection of Oxaliplatin induced DNA damage in G-quadruplex structures.
Osmanoğulları SC; Forough M; Persil Çetinkol Ö; Arslan Udum Y; Toppare L
Anal Biochem; 2023 Jun; 671():115149. PubMed ID: 37030427
[TBL] [Abstract][Full Text] [Related]
5. Ultrafast Electron Transfer in Complexes of Doxorubicin with Human Telomeric G-Quadruplexes and GC Duplexes Probed by Femtosecond Fluorescence Spectroscopy.
Changenet-Barret P; Gustavsson T; Markovitsi D; Manet I
Chemphyschem; 2016 May; 17(9):1264-72. PubMed ID: 26790038
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of G-quadruplex structure on vascular endothelial growth factor gene promoter depends on CpG methylation site and cation type.
Yoshida W; Terasaka M; Laddachote S; Karube I
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1933-1937. PubMed ID: 29940278
[TBL] [Abstract][Full Text] [Related]
7. Ionic Effects on VEGF G-Quadruplex Stability.
Kim BG; Long J; Dubins DN; Chalikian TV
J Phys Chem B; 2016 Jun; 120(22):4963-71. PubMed ID: 27196695
[TBL] [Abstract][Full Text] [Related]
8. Interactions between a Bioflavonoid and c-MYC Promoter G-Quadruplex DNA: Ensemble and Single-Molecule Investigations.
Paul S; Hossain SS; M BD; Samanta A
J Phys Chem B; 2019 Mar; 123(9):2022-2031. PubMed ID: 30758965
[TBL] [Abstract][Full Text] [Related]
9. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
10. Carbazole ligands as c-myc G-quadruplex binders.
Głuszyńska A; Juskowiak B; Kuta-Siejkowska M; Hoffmann M; Haider S
Int J Biol Macromol; 2018 Jul; 114():479-490. PubMed ID: 29581003
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexes.
Agrawal P; Hatzakis E; Guo K; Carver M; Yang D
Nucleic Acids Res; 2013 Dec; 41(22):10584-92. PubMed ID: 24005038
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an Analogue of the Marine ε-PLL Peptide as a Ligand of G-quadruplex DNA Structures.
Marzano M; Falanga AP; Marasco D; Borbone N; D'Errico S; Piccialli G; Roviello GN; Oliviero G
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31940851
[TBL] [Abstract][Full Text] [Related]
13. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
[TBL] [Abstract][Full Text] [Related]
14. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents.
Sun D; Guo K; Rusche JJ; Hurley LH
Nucleic Acids Res; 2005; 33(18):6070-80. PubMed ID: 16239639
[TBL] [Abstract][Full Text] [Related]
15. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
16. Selectivity and Targeting of G-Quadruplex Binders Activated by Adaptive Binding and Controlled by Chemical Kinetics.
Zhu BC; He J; Liu W; Xia XY; Liu LY; Liang BB; Yao HG; Liu B; Ji LN; Mao ZW
Angew Chem Int Ed Engl; 2021 Jul; 60(28):15340-15343. PubMed ID: 33899272
[TBL] [Abstract][Full Text] [Related]
17. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
[TBL] [Abstract][Full Text] [Related]
18. CpG Methylation Changes G-Quadruplex Structures Derived from Gene Promoters and Interaction with VEGF and SP1.
Tsukakoshi K; Saito S; Yoshida W; Goto S; Ikebukuro K
Molecules; 2018 Apr; 23(4):. PubMed ID: 29670067
[TBL] [Abstract][Full Text] [Related]
19. Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO
Zhu R; Wang Z; Liang P; He X; Zhuang X; Huang R; Wang M; Wang Q; Qian Y; Wang S
Acta Biomater; 2017 Nov; 63():163-180. PubMed ID: 28923539
[TBL] [Abstract][Full Text] [Related]
20. Preferential Binding of a Red Emissive Julolidine Derivative to a Promoter G-Quadruplex.
Metangle S; Ranjan N
Chembiochem; 2024 Feb; 25(3):e202300527. PubMed ID: 37926689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
